The first time a clinic used the phrase “diminished ovarian reserve” to me, I nodded as though I understood what it meant. I didn’t. I went home and spent an hour trying to work out whether it was a diagnosis, a warning, or a death sentence for my treatment options. It was none of those things — but I didn’t know that at the time.
This glossary covers the terms that come up repeatedly in consultations, test results, and clinic communications for women over 40. Each entry explains what the term means, and where relevant, what it does not mean — which is sometimes the more useful piece of information.
- AFC — Antral Follicle Count test result
- A count of the small resting follicles visible on an ultrasound scan at the start of your cycle. Each follicle has the potential to produce an egg. A low AFC suggests lower ovarian reserve and typically means fewer eggs retrieved per cycle. Like AMH, it indicates quantity — not quality. A low count does not mean a cycle cannot produce viable embryos.
- AMH — Anti-Müllerian Hormone test result
- A blood test that measures ovarian reserve — an indication of how many eggs you are likely to have remaining. A low AMH in your 40s is common and expected; it is not a verdict on whether IVF can work. AMH reliably predicts how you are likely to respond to stimulation (how many eggs a cycle might retrieve). It does not predict egg quality, fertilisation rate, or whether a pregnancy will result. See what your AMH results actually mean for a full explanation.
- Aneuploid / Aneuploidy
- An embryo that has an abnormal number of chromosomes. Chromosomally normal embryos have 46 chromosomes (23 pairs); aneuploid embryos have too many or too few. Aneuploid embryos usually fail to implant or result in early miscarriage. The proportion of aneuploid embryos increases with age, which is one of the main reasons IVF success rates decline for women over 40. An all-aneuploid result on a PGT-A test means no embryos from that cycle were suitable for transfer — it does not mean future cycles cannot produce normal embryos.
- Antagonist protocol
- A stimulation protocol used in IVF to prevent premature ovulation. Hormone injections (gonadotrophins) stimulate the ovaries to produce multiple follicles. A second medication (an antagonist) is added partway through to prevent the body from releasing eggs before retrieval. Often used for women with lower ovarian reserve. Compare with long protocol below.
- Blastocyst
- An embryo that has developed to day 5 or 6 after fertilisation. A blastocyst has differentiated into two types of cells: those that will form the foetus (inner cell mass) and those that will form the placenta (trophectoderm). Blastocyst-stage embryos have a higher implantation rate than earlier-stage (day 3) embryos and are required for PGT-A testing. Not all fertilised eggs reach blastocyst stage — for women over 40, this attrition rate can be high.
- Blastocyst grading
- A scoring system clinics use to assess embryo quality at day 5 or 6. Common grading systems score expansion (how far the blastocyst has expanded), inner cell mass quality, and trophectoderm quality — often expressed as something like 4AA or 3BB. Grading gives an indication of developmental quality but is not a reliable predictor of live birth outcome. A lower-graded embryo can result in a healthy pregnancy; a highly graded embryo can fail to implant.
- Chromosomal screening
- See PGT-A.
- Cryopreservation
- The process of freezing eggs or embryos for use in future cycles. Embryos are typically vitrified (fast-frozen) rather than slow-frozen. Frozen embryo transfer (FET) cycles have broadly comparable success rates to fresh transfers in most clinics. Annual storage fees (typically £200–£500 per year) are usually not included in the quoted cycle price.
- Cumulative success rate
- The probability of a live birth across multiple cycles or transfers, rather than a single attempt. For women over 40, cumulative rates across two or three cycles are significantly higher than single-cycle rates. Clinics rarely volunteer this figure; it is worth asking for.
- Day 3 embryo transfer
- Transferring an embryo on day 3 of development (at the 6–8 cell stage), rather than waiting until day 5 (blastocyst). Some clinics prefer day 3 transfer when embryo numbers are low, on the basis that the uterine environment may be more suitable than the lab for embryos that are developing slowly. Others extend all embryos to blastocyst where possible.
- Diminished ovarian reserve (DOR)
- A clinical description indicating lower than expected ovarian reserve for age, based on AMH, AFC, or FSH results. It is a description of likely response to stimulation — not a verdict on whether IVF can work or whether eggs are of good quality. Women with DOR often retrieve fewer eggs per cycle but can produce chromosomally normal embryos.
- Donor eggs / donor egg IVF
- IVF using eggs from a donor, typically a woman under 35. Success rates for donor egg IVF are broadly age-independent — running at around 25–35% per transfer in most clinics — because the eggs are younger. The decision to use donor eggs is significant medically and personally. It should be made on the basis of your specific circumstances, not age alone. See own eggs or donor eggs after 40.
- Egg collection / egg retrieval
- The procedure in which mature eggs are retrieved from the ovaries under light sedation or general anaesthetic. A needle is passed through the vaginal wall to aspirate fluid from each follicle. It typically takes 15–30 minutes. Recovery time varies; most clinics expect you to have someone with you on the day. As a solo woman attending alone, it is worth confirming in advance what support the clinic provides.
- Embryo transfer
- The procedure in which one or more embryos are placed into the uterus using a thin catheter. It is usually straightforward and does not require sedation. The number of embryos transferred is typically one (single embryo transfer, or SET) in UK clinics to reduce the risk of multiple pregnancy.
- Endometrial receptivity
- How ready the uterine lining is to receive an embryo. Some clinics offer ERA (Endometrial Receptivity Analysis) testing as an add-on to identify the optimal window for transfer. Its clinical effectiveness is debated; the HFEA currently rates it as “red” (no evidence of benefit in routine use).
- FET — Frozen Embryo Transfer
- A cycle in which a previously frozen embryo is thawed and transferred. Usually involves a shorter, simpler preparation than a fresh cycle — typically oestrogen and progesterone rather than full stimulation. Success rates are broadly comparable to fresh transfers.
- Follicle
- A fluid-filled sac in the ovary that contains a developing egg. During stimulation, the goal is for multiple follicles to grow to a mature size (typically 17–20mm) before egg collection. Follicle growth is monitored by ultrasound scan during the stimulation phase.
- FSH — Follicle-Stimulating Hormone test result
- A hormone produced by the pituitary gland that stimulates follicle development. High FSH on a Day 3 blood test indicates the body is working harder to stimulate the ovaries — a sign of lower ovarian reserve. Like AMH and AFC, it is a marker of reserve, not a prediction of IVF outcome.
- HFEA — Human Fertilisation and Embryology Authority
- The UK regulator for fertility clinics and research. All UK clinics must be licensed by the HFEA. The HFEA publishes clinic-specific success rate data on its website, which is one of the most useful resources for comparing clinics before you commit to treatment. Clinics abroad are not regulated by the HFEA.
- Hysteroscopy
- A procedure to examine the inside of the uterus using a thin telescope. Sometimes recommended before IVF to check for polyps, fibroids, or other abnormalities that could affect implantation. Usually outpatient, without general anaesthetic.
- ICSI — Intracytoplasmic Sperm Injection
- A form of fertilisation in which a single sperm is injected directly into an egg, rather than allowing sperm and eggs to fertilise in a dish. Often recommended when sperm quality is a factor, or when using donor sperm (where sperm numbers may be limited). Some clinics use ICSI routinely; the HFEA notes there is no evidence it improves outcomes compared to standard IVF when there is no male factor issue.
- Implantation failure
- When a transferred embryo does not successfully implant in the uterine lining. It is the most common reason IVF cycles fail. Recurrent implantation failure (RIF) — typically defined as two or more failed transfers with good quality embryos — may prompt further investigation. Some clinics offer additional add-ons in response to implantation failure; evaluating the evidence for each is worth doing before agreeing to additional cost.
- Live birth rate
- The proportion of cycles that result in a live birth. This is the figure that matters most when comparing clinics or evaluating your own odds — not pregnancy rate, not positive test rate, not heartbeat rate. Clinics are required to report live birth rates to the HFEA. Always ask for live birth rate per cycle started, at your specific age.
- Long protocol (long down-regulation)
- A stimulation protocol in which a medication (usually a nasal spray or injection) is used first to suppress the natural menstrual cycle, before stimulation begins. Less commonly used now than antagonist protocols, but still used in some cases. Takes longer and involves more injections than an antagonist cycle.
- Mature egg (MII)
- An egg that has completed the first stage of meiosis and is ready for fertilisation. Not all retrieved eggs will be mature. Immature eggs cannot be fertilised. Maturity rate varies by individual and stimulation protocol.
- Monitoring scan
- An ultrasound scan during the stimulation phase of IVF to track follicle growth. Usually 2–4 scans are needed per cycle. In UK clinics these are typically included in the cycle price; at some clinics abroad they may be an additional cost, or you may be asked to have some done locally. Clarify this before you book.
- OHSS — Ovarian Hyperstimulation Syndrome
- A response to fertility drugs in which the ovaries become swollen and painful. Mild OHSS is common and usually resolves on its own; severe OHSS is rare but requires medical attention. Risk is generally lower for women with lower ovarian reserve. If a cycle produces an unexpectedly high number of follicles, a clinic may recommend freezing all embryos and delaying transfer to allow OHSS to resolve before a frozen transfer cycle.
- Ovarian reserve
- The quantity of eggs remaining in the ovaries. Measured indirectly through AMH, AFC, and FSH. Reserve declines with age. Low reserve in your 40s is expected — it indicates how many eggs are likely to be retrieved per cycle, not whether those eggs are viable or whether IVF can succeed.
- PGT-A — Preimplantation Genetic Testing for Aneuploidy
- A test performed on embryos at blastocyst stage to check the number of chromosomes. Embryos found to be chromosomally abnormal (aneuploid) are not transferred. PGT-A is often recommended for women over 40 on the basis that aneuploidy rates are higher with age. Its clinical benefit is disputed: some studies show improved implantation rates per transfer; others suggest that some aneuploid embryos are self-correcting and may have developed normally without screening. It is not a mandatory part of IVF. Weigh the cost and the evidence before agreeing to it. See IVF add-ons and hidden costs.
- Poor responder
- A clinical description for a patient who produces fewer follicles than expected in response to stimulation — typically defined as fewer than 4 follicles or fewer than 4 eggs retrieved. Poor response is more common with lower ovarian reserve. It may prompt a clinic to adjust the stimulation protocol, increase medication doses, or discuss alternative approaches.
- Progesterone support
- Progesterone supplements (pessaries, injections, or gel) given after egg collection or embryo transfer to support the uterine lining and early pregnancy. Usually continued until 10–12 weeks of pregnancy. Typically included in the cycle price but worth confirming.
- Retrieval rate
- The number of eggs retrieved compared to the number of follicles visible before egg collection. Not all follicles contain a mature egg; some may be empty. A lower retrieval rate can be a sign of egg maturity issues, though some variation is normal.
- Stimulation protocol
- The combination of medications and schedule used during the stimulation phase of IVF to encourage multiple follicles to grow. The protocol is chosen based on your test results, previous response if applicable, and clinic preference. Common protocols include antagonist and long protocol (see above). The choice of protocol can affect how many eggs are retrieved and how you respond to treatment.
- Trigger injection
- A single injection (usually hCG or a GnRH agonist) given at a precise time before egg collection to trigger final egg maturation. Timing is critical — egg collection is typically scheduled exactly 36 hours after the trigger. Missing the timing window affects the cycle outcome.
- Two-week wait (TWW)
- The period between embryo transfer and the pregnancy test. Typically 10–14 days. One of the most difficult parts of IVF for most women — particularly when you are going through it alone. See the two-week wait as a solo woman.
- Uterine lining (endometrium)
- The lining of the uterus that thickens in preparation for implantation. A minimum thickness of around 7mm is typically required for transfer; 8–10mm is considered optimal. Lining thickness is checked by ultrasound in the lead-up to transfer. Thin lining can delay or cancel a transfer cycle.
The IVF guide clinics won’t give you
A structured guide to IVF for solo women over 40 — covering test results, costs, clinic selection, and what to know before you spend five figures.
Get the IVF guide →